05 December 2017 | News
The investment will bolster the company’s ambition of becoming a leading provider of healthcare products and services in India.
Image credit- drrosedale.com
Singapore based investment firm Clermont Group has invested Rs 155 Cr capital in Indiabulls Pharmaceuticals, a one year old pharma venture of Indiabulls Group Companies.
This new development will further boost an already rapidly growing business which the company has witnessed since its launch in May 2017.
The investment will bolster the company’s ambition of becoming a leading provider of healthcare products and services in India and be amongst the top 10 players in the coming decade.
The new development provides capital for growth for years to come and puts Indiabulls Pharmaceuticals on a firm path to be a leading pharmaceutical company in the coming decade.
The Indiabulls Group has businesses spanning housing finance, consumer finance, real estate, and pharmaceuticals sectors.
The business aspiration of Indiabulls Pharma is to be a leading patient and physician centric, best in class, innovative healthcare company. It operates in both chronic and acute therapies and also across health, wellness and cosmoceutical categories. Currently the company has 300 products under its portfolio many being first time in India formulations and devices.